Inventaire - your friends and communities are your best library

CD133: to be or not to be, is this the real question?

published in: American Journal of Translational Research

date of publication: 2013

language: English

Cites articles 122

Date

Title

Authors

2013-07-06

CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy

José Antonio Lorente
2013-05-02

TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction

Virginia Tirino, Francesca Paino, Maria Vincenza Carriero, Nicola Normanno, Gaetano Rocco
2013-03-22

Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review
2013-10-16

Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.
2013-07-01

CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchymal transition
2013-02-19

Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer

Giosuè Scognamiglio, Renato Franco, Monica Cantile, Nicola Normanno, Gaetano Rocco, Rosa Camerlingo, Virginia Tirino
2012-12-01

CD133: holy of grail of neuro-oncology or promiscuous red-herring?
2012-09-12

Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer

Antonio Giordano, Simone Anfossi, Evan N Cohen, Michelino De Laurentiis, Sendurai A. Mani, Francisco J Esteva
2012-11-20

CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges

Leoni Kunz-Schughart
2012-06-01

A Prominin-1-Rich Pediatric Glioblastoma: Biologic Behavior Is Determined by Oxygen Tension-Modulated CD133 Expression but Not Accompanied by Underlying Molecular Profiles
2012-06-01

CD133 negatively regulates tumorigenicity via AKT pathway in synovial sarcoma
2012-03-28

Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulolobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis [corrected].

Gerardo Botti, Margherita Cerrone, Laura Marra, Francesca Collina, Giuseppina Liguori, Monica Cantile, Maurizio Di Bonito
2012-10

Circulating tumor cells as emerging tumor biomarkers in lung cancer

Monica Cantile, Renato Franco, Federica Zito Marino
2012-06-01

CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors

Renato Franco, Gerardo Nardone
2012-11-01

[Usefulness of CTCs in tumor drainage vein blood as a biomarker for prognosis in colorectal cancer patients with Dukes' stage B and C]

Soichiro Ishihara
2011-12-12

CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133- cells

Mark R. Hellmich
2011-09-22

Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
2011-09-21

CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope
2011-06-30

Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line

Nicola Normanno, Renato Franco, Gaetano Rocco, Francesca Paino, Nicola Martucci
2011-04-15

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival

Max S Wicha
2011-03-08

Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo

Virginia Tirino, Vincenzo Desiderio, Francesca Paino
2011-04-09

Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.

Dominique Figarella-Branger
2010-06-01

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression
2010-01-15

The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation

Giorgio Stassi
2010-12-01

Glycan changes: cancer metastasis and anti-cancer vaccines
2010-12-04

Prognostic value of CD133 expression in stage I lung adenocarcinomas

Koji Okudela
2010-10-11

CD133(+) cells isolated from various sources and their role in future clinical perspectives

Mirella Meregalli, Yvan Torrente
2010-08-30

Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer
2010-05-12

Epigenetics and gene expression
2010-04-01

What goes around, comes around: a review of circulating tumor cells
2010-02-19

Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks

Tetsuya Taga
2010-01-12

Circulating tumor cells: a window into cancer biology and metastasis

Article - wd:Q24615405

Welcome to Inventaire

the library of your friends and communities

learn more